Postlethwaite AE - Search Results

1

Vascular involvement in systemic sclerosis (scleroderma).

Pattanaik D, Brown M, Postlethwaite AE. Pattanaik D, et al. Among authors: postlethwaite ae. J Inflamm Res. 2011;4:105-25. doi: 10.2147/JIR.S18145. Epub 2011 Jul 26. J Inflamm Res. 2011. PMID: 22096374 Free PMC article.

2

Pathogenesis of Systemic Sclerosis.

Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pattanaik D, et al. Among authors: postlethwaite bc, postlethwaite ae. Front Immunol. 2015 Jun 8;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015. Front Immunol. 2015. PMID: 26106387 Free PMC article. Review.

3

A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.

Pattanaik D, Postlethwaite AE. Pattanaik D, et al. Among authors: postlethwaite ae. Discov Med. 2010 Aug;10(51):161-7. Discov Med. 2010. PMID: 20807477 Free article. Review.

4

Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.

Brown M, Postlethwaite AE, Myers LK, Hasty KA. Brown M, et al. Among authors: postlethwaite ae. Clin Rheumatol. 2012 Jun;31(6):973-81. doi: 10.1007/s10067-012-1962-z. Epub 2012 Feb 25. Clin Rheumatol. 2012. PMID: 22367096 Free PMC article.

5

Rheumatoid arthritis and periodontal disease: What are the similarities and differences?

Li R, Tian C, Postlethwaite A, Jiao Y, Garcia-Godoy F, Pattanaik D, Wei D, Gu W, Li J. Li R, et al. Int J Rheum Dis. 2017 Dec;20(12):1887-1901. doi: 10.1111/1756-185X.13240. Epub 2018 Jan 9. Int J Rheum Dis. 2017. PMID: 29341486 Review.

6

20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.

Slominski A, Janjetovic Z, Tuckey RC, Nguyen MN, Bhattacharya KG, Wang J, Li W, Jiao Y, Gu W, Brown M, Postlethwaite AE. Slominski A, et al. Among authors: postlethwaite ae. J Clin Endocrinol Metab. 2013 Feb;98(2):E298-303. doi: 10.1210/jc.2012-3074. Epub 2013 Jan 7. J Clin Endocrinol Metab. 2013. PMID: 23295467 Free PMC article.

7

Pharmacotherapy of systemic sclerosis.

Postlethwaite AE, Harris LJ, Raza SH, Kodura S, Akhigbe T. Postlethwaite AE, et al. Expert Opin Pharmacother. 2010 Apr;11(5):789-806. doi: 10.1517/14656561003592177. Expert Opin Pharmacother. 2010. PMID: 20210685 Free PMC article. Review.

8

Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts.

Yin Z, Carbone LD, Gotoh M, Postlethwaite A, Bolen AL, Tigyi GJ, Murakami-Murofushi K, Watsky MA. Yin Z, et al. Rheumatology (Oxford). 2010 Dec;49(12):2290-7. doi: 10.1093/rheumatology/keq260. Epub 2010 Sep 7. Rheumatology (Oxford). 2010. PMID: 20823096 Free PMC article.

9

Platelet contributions to the pathogenesis of systemic sclerosis.

Postlethwaite AE, Chiang TM. Postlethwaite AE, et al. Curr Opin Rheumatol. 2007 Nov;19(6):574-9. doi: 10.1097/BOR.0b013e3282eeb3a4. Curr Opin Rheumatol. 2007. PMID: 17917538 Review.

10

Connective tissue metabolism including cytokines in scleroderma.

Postlethwaite AE. Postlethwaite AE. Curr Opin Rheumatol. 1995 Nov;7(6):535-40. doi: 10.1097/00002281-199511000-00012. Curr Opin Rheumatol. 1995. PMID: 8579975 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page